La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

evertex fabrinology Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Anthony Yeh

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	n/a
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	4.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02

AMMINISTRATORE DELEGATO

Anthony Yeh

no data

Mandato

Poliang Yeh, also known as Anthony, is President of evertex fabrinology limited.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Ye Qingze	Director	no data	Nessun dato	2.21% NT$ 48.6m
Xu Rongxin	Director	no data	Nessun dato	2.89% NT$ 63.5m
Ye Guohui	Director	no data	Nessun dato	0.30% NT$ 6.6m
Yang Yaozhou	Director	no data	Nessun dato	3.71% NT$ 81.5m
Ye Zhiming	Director	4.6yrs	Nessun dato	Nessun dato
Funan Zhou	Independent Director	no data	Nessun dato	Nessun dato
Binghuang Lin	Independent Director	no data	Nessun dato	Nessun dato
Bai Liang Ye	Director	4.6yrs	Nessun dato	4.68% NT$ 102.7m
Wu Zhong Liao	Independent Director	4.6yrs	Nessun dato	Nessun dato
Fa Yeh Chuan	Chairman of the Board	no data	Nessun dato	Nessun dato

4.6yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1470 sono considerati esperti (durata media dell'incarico 4.6 anni).

evertex fabrinology Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

evertex fabrinology limited, Annual General Meeting, Jun 25, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: NT$0.27 (vs NT$0.10 in 2Q 2023)

evertex fabrinology limited to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$0.58 per share

First quarter 2024 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2023)

Dividend increased to NT$0.58

Evertex Fabrinology Ltd. Announces Cash Dividend, Payable on August 16, 2024

evertex fabrinology limited to Report Q1, 2024 Results on May 10, 2024

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: NT$0.58 (vs NT$0.38 in FY 2022)

evertex fabrinology limited, Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings released: EPS: NT$0.06 (vs NT$0.15 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$0.10 (vs NT$0.071 loss in 2Q 2022)

Upcoming dividend of NT$0.45 per share at 2.3% yield

Full year 2022 earnings released: EPS: NT$0.38 (vs NT$0.76 in FY 2021)

Less than half of directors are independent

Second quarter 2022 earnings released: NT$0.07 loss per share (vs NT$0.34 profit in 2Q 2021)

Upcoming dividend of NT$0.80 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: NT$0.31 (vs NT$0.076 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: NT$0.76 (vs NT$0.41 in FY 2020)

Third quarter 2021 earnings released: EPS NT$0.15 (vs NT$0.11 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.11 loss in 2Q 2020)

Upcoming dividend of NT$0.42 per share

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Full year 2020 earnings released: EPS NT$0.41 (vs NT$0.89 in FY 2019)

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

New 90-day low: NT$17.55

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Third quarter 2020 earnings released: EPS NT$0.11

New 90-day low: NT$17.50

New 90-day low - NT$17.75

First half earnings released

Upcoming Dividend of NT$0.80 Per Share

AMMINISTRATORE DELEGATO

Mandato

Membri del Consiglio di amministrazione

Durata media